The role of LIF/LIFR autocrine signaling in tumor recurrence is substantial since following chemotherapy, residual CSCs might repopulate tumor once again utilizing positive autocrine loop without the need of paracrine factors from the host tissue. The gene discussed is LIFR; the disease is neoplasm.